Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
quilizumab (MEMP1972A) (RG7449)
print preview
bookmark
share with colleague
General Information
Company
Roche
Description
Humanized mAb against M1 prime segment of membrane IgE
Molecular Target
Immunoglobulin E (IgE)
Mechanism of Action
Latest Stage of Development
Phase II
Indication
Asthma
Partner
Genentech Inc.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy